ロード中...
Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
Hypoxia, a characteristic of most human solid tumors, is a major obstacle to successful radiotherapy. While moderate acute hypoxia increases cell survival, chronic cycling hypoxia triggers adaptation processes, leading to the clonal selection of hypoxia-tolerant, apoptosis-resistant cancer cells. Ou...
保存先:
| 出版年: | Cell Death Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8277842/ https://ncbi.nlm.nih.gov/pubmed/34257274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-021-03971-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|